2025-07-10 Drugs The SFDA Approves the Registration of “Winrevair” for the Treatment of Pulmonary Arterial Hypertension under the Orphan Drug Designation Pathway
2025-07-02 Medical Devices SFDA Rejects AI-Powered Diabetes Prediction Device for Failing Safety and Efficacy Standards
2025-06-30 Medical Devices SFDA Approves Marketing Authorization for Advanced Brain-Stimulation Medical Device for Parkinson's Disease
